Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023. H.R. 3884. 118th Cong., 2nd sess., Referred in Senate September 24, 2024. https://www.govinfo.gov/app/details/BILLS-118hr3884rfs.
Congress, Senate (2024, September 24). Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 (H.R. 3884 (RFS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-118hr3884rfs.
United States, Congress, Senate. Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-118hr3884rfs. 118th Congress, H.R. 3884, Referred in Senate 24 Sep. 2024.
H.R.3884 - 118th Congress (2023-2024): Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023, H.R.3884, 118th Cong. (2024), https://www.govinfo.gov/app/details/BILLS-118hr3884rfs.